Global Dengue Vaccine Market is valued at USD 325.4 Million in 2021 and is expected to reach USD 964.9 Million by 2028 with a CAGR of 16.8% over the forecast period.
Global Dengue Vaccine Market: Global Size, Trends, Competitive, Historical & Forecast Analysis, 2021-2028– Increasing incidences of dengue fever, rising clinical trials of dengue vaccines, and rising number of government initiatives controlling the dengue outbreak are major factors anticipated to drive the growth of The Global Dengue Vaccines Market.
Get Sample Report: https://brandessenceresearch.com/requestSample/PostId/1948
Scope of Global Dengue Vaccine Market Report:-
Dengue vaccine is gives protection against dengue fever in humans. The vaccine for dengue has been difficult task as it has 4 variants and each of the variant has seen in particular season. The mosquito Aedes species mosquito spread dengue viruses to humans through the bite. Dengue is caused by one of any of four related viruses are dengue virus 1, 2, 3, 4. Dengue can become serious as platelets were reduced in the infection and it can be deadly sometimes. There is no remedy for dengue, and treatment has been given as per the symptoms. Thus, vaccination is the preventive measure taken against dengue. The dengue vaccine development has been started since 1920s. However, the successful dengue vaccine has been developed in 2021.
The Covid-19 pandemic has also impacted on the global dengue vaccine market. The Covid-19 vaccine development has been given the priority by healthcare industry and the vaccination of dengue has been slowed down. The supply chain disruptions and restrictions on research and development of dengue vaccine due to the lack of raw material hamper the market during the Covid-19 pandemic.
Global Dengue Vaccine Market Segmentation:-
The global dengue vaccine market is segmented into on the basis of type, application, and region & country level. On the basis of type, the global dengue vaccine market is segmented into CYD-TDV, Tak-003, and others. On the basis of application, the market is segmented into hospitals, government institutes, non-governmental organizations (NGOs), and others.
- Government Institutes
- Non-Governmental Organizations (NGOs)
Key Players of Global Dengue Vaccine Market:-
Some of the key players for global dengue vaccine market are
- Glaxo Smith Kline
- Merck Sharp & Dohme
- Takeda Pharmaceuticals
- GeneOne Life Sciences Inc.
- Medigen Biologics
- Panacea Biotec
- Sun Pharmaceutical. U.S NIH
News: Takeda Revealed New Dengue Vaccine Manufacturing Plant in Germany
On November 5th, 2019; Takeda Pharmaceutical Company Limited announced the starting of its innovative manufacturing plant in Singen, Germany, for its dengue vaccine candidate known as TAK-003. The Singen vaccine plant will be utilized for formulation, fill, finish and secondary packaging of the dengue vaccine candidate starting with the packaging line. Takeda invested more than 130 million Euro and will employ up to 200 employees in the vaccine plant.
Increasing Incidences of Dengue Fever, Rising Number of Clinical Trials of Dengue Vaccines and Rising Number of Government Initiatives Controlling the Dengue Outbreak are Driving the Market Growth
Asia Pacific Expected as Fastest Growing Region in the Global Dengue Vaccine Market
Asia Pacific is expected to witness a fastest growth in the global dengue vaccine market due to rising prevalence of dengue, increasing demand for vaccines and growing adoption of dengue vaccines and government awareness programmes in this region. For instance; according to World Health Organization for the period of 2019-2024 dengue is one of the top ten diseases. Also, increasing demand of vaccines in Asia pacific region for controlling disease is also supplementing the market growth in this region. For instance; according to International Vaccine Institute; South Korea, from 2015-2022 vaccination schedule for routine vaccination against dengue around 7.8–62.9 million doses of dengue vaccine are needed. Moreover, on October 7th, 2021, Takeda’s TAK-003 vaccine is in the process of approval for use in India which has been shown to prevent hospitalizations in 83.6% of trial participants and 62% reduction in dengue illness. This approval will further acerate the growth of the dengue vaccines in Asia Pacific region.
North America is expected to show a significant growth in the global dengue vaccine market due to the highly developed healthcare infrastructure, and high awareness about dengue vaccines in this region. For instance; in May 2019, Food & Drug Administration (FDA) granted permission for the use of Sanofi’s Dengvaxia which is live attenuated vaccine for 9–16-year-old children. Additionally, North America’s highly developed healthcare infrastructure also providing growth to the global dengue vaccines market within the forecast period.
Get Full Report: https://brandessenceresearch.com/requestSample/PostId/1948
This comprehensive report will provide:
- Enhance your strategic decision making
- Assist with your research, presentations and business plans
- Show which emerging market opportunities to focus on
- Increase your industry knowledge
- Keep you up-to-date with crucial market developments
- Allow you to develop informed growth strategies
- Build your technical insight
- Illustrate trends to exploit
- Strengthen your analysis of competitors
- Provide risk analysis, helping you avoid the pitfalls other companies could make
- Ultimately, help you to maximize profitability for your company.
Our Market Research Solution Provides You Answer to Below Mentioned Question:
- Which are the driving factors responsible for the growth of market?
- Which are the roadblock factors of this market?
- What are the new opportunities, by which market will grow in coming years?
- What are the trends of this market?
- Which are main factors responsible for new product launch?
- How big is the global & regional market in terms of revenue, sales and production?
- How far will the market grow in forecast period in terms of revenue, sales and production?
- Which region is dominating the global market and what are the market shares of each region in the overall market in 2022?
- How will each segment grow over the forecast period and how much revenue will these segments account for in 2028?
- Which region has more opportunities?
About us: Brandessence Market Research and Consulting Pvt. Ltd.
Brandessence market research publishes market research reports & business insights produced by highly qualified and experienced industry analysts. Our research reports are available in a wide range of industry verticals including aviation, food & beverage, healthcare, ICT, Construction, Chemicals, and lot more. Brand Essence Market Research report will be best fit for senior executives, business development managers, marketing managers, consultants, CEOs, CIOs, COOs, and Directors, governments, agencies, organizations, and Ph.D. Students. We have a delivery center in Pune, India and our sales office is in London.
Contact us at: +44-2038074155 or mail us at email@example.com